[Epidemiology of designer drug use in Spain].
BACKGROUND
To provide epidemiological information on the extent of design drug use in Spain, the characteristics of users, and the types of substances consumed.


METHODS
We analyzed two surveys on drug use carried out in 1993 and 1994 (one in the general population older than 15 years and the other in heroin and/or cocaine users who were not in treatment) as well as data on designer drug seizures confiscated by the General Police Headquarters and Ministry of Health laboratories.


RESULTS
According to the general population survey, 4.5% of persons 16-40 years of age have tried design drugs at some time, 2.1% more than once, and 0.6% are current users. Design drug use is associated with age of 20-24 years and use of crack (odds ratio [OR] = 28.6), cannabis (OR = 12.5), cocaine (OR = 7.6) or heroin (OR = 3.8). According to the survey of heroin/cocaine users, 25% of cocaine users have used design drugs in the last 30 days, 11% of heroin users, and 18% of those who use both substances. Use is associated with the use of hallucinogens (OR = 4.8), non-use of the injected route (OR = 2), and having been interviewed in recreational areas (OR = 1.8). Police data reflect a stability in the quantities of amphetamines confiscated, a large increase in those of MDMA, and an absence of MDA and MDEA. Ministry of Health laboratories show an increase in confiscations of amphetamines and the presence of MDA, MDMA and MDEA in all years and areas studied, as well as the appearance of MBDB in 1994.


CONCLUSIONS
The occasional use of different design drugs has spread to some degree among young people, varies considerably by geographic region, and is associated with the use of other legal and illegal substances, specially stimulants.
de la Fuente de Hoz
L
L
Delegación del Gobierno para el Plan Nacional sobre Drogas, Madrid.
Rodríguez Arenas
M A
MA
Vicente Orta
J
J
Sánchez Payá
J
J
Barrio Anta
G
G
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives; D000293:Adolescent; D000328:Adult; D003042:Cocaine; D015198:Designer Drugs; D005260:Female; D003932:Heroin; D006801:Humans; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D015995:Prevalence; D013030:Spain / Q000453:epidemiology; D019966:Substance-Related Disorders / Q000453:epidemiology*
D015198:Designer Drugs; D015104:3,4-Methylenedioxyamphetamine; D003932:Heroin; D003042:Cocaine; D018817:N-Methyl-3,4-methylenedioxyamphetamine; C051800:3,4-methylenedioxyethamphetamine
Epidemiología del consumo de drogas de diseño en España.